MIKI Yoshio | Department of Genetic Diagnosis, the Cancer Institute Hospital of JFCR

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Recurrence Pattern and Rapid Intraoperative Detection of Carcinoembryonic Antigen (CEA) mRNA in Pleural Lavage in Patients with Non-Small Cell Lung Cancer (NSCLC)
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
Clinicopathological Features of Hereditary Breast Cancer
Identification of Rad51 alteration in patients with bilateral breast cancer
High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer
Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage
The cell death machinery governed by the p53 tumor suppressor in response to DNA damage
Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
Retrotransposal integration of mobile genetic elements in human diseases
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer
BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization

もっと見る

スポンサーリンク